VAERS Explorer
Back to explore

Report #2887140

Received Feb 27, 2026

ER / ED visitOffice visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
63 yrs
State
Recovered
Not recovered
Vaccinated
May 15, 2024
Onset
May 15, 2024
Days to onset
0
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER2UNK

Symptoms (3)

Emotional disorderFacial painVisual impairment

Symptom narrative

Eyesight off; other emotions too; facial pain; 1st dose received on 03-FEB-2021 and 2nd dose received on 15-MAY-2024; This non-serious case was reported by a consumer and described the occurrence of facial pain in a 63-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included facial neuralgia (nerve pain in face) and neuralgia (nerve pain in head). Previously administered products included Varicella zoster vaccine (1st dose of Shingles vaccine received on 03-FEB-2021). Concurrent medical conditions included blood pressure (heart blood pressure). Concomitant products included aspirin. On 15-MAY-2024, the patient received the 2nd dose of Shingles vaccine. On 15-MAY-2024, an unknown time after receiving Shingles vaccine, the patient experienced drug dose administration interval too long (Verbatim: 1st dose received on 03-FEB-2021 and 2nd dose received on 15-MAY-2024). On 16-MAY-2024, the patient experienced facial pain (Verbatim: facial pain). On an unknown date, the patient experienced visual impairment (Verbatim: Eyesight off) and emotional disorder (Verbatim: other emotions too). The outcome of the facial pain, visual impairment and emotional disorder were not resolved and the outcome of the drug dose administration interval too long was not applicable. It was unknown if the reporter considered the facial pain, visual impairment and emotional disorder to be related to Shingles vaccine. It was unknown if the company considered the facial pain, visual impairment and emotional disorder to be related to Shingles vaccine. Additional Information: GSK Receipt Date:19-FEB-2026 The patient self-reported this case for himself The patient stated that he had 5 ER (emergency room) visits and 3 neurologist appointments, along with many regular physician appointments. Further he reported that he had received lots of diagnosis and was still hurting, and that his eyesight was off, and he had other emotions too. The batch number was not provided and a request for this information had been made.

Current illness

Blood pressure (heart blood pressure)

Medical history

Medical History/Concurrent Conditions: Facial neuralgia (nerve pain in face); Neuralgia (nerve pain in head)

Other medications

ASPIRIN